Related Experiment Video
Updated: Aug 13, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Diagnosis and management of Kawasaki disease
1Division of Pediatric Cardiology, College of Physicians and Surgeons, Columbia University, New York, NY.
Insights
Kawasaki disease is an acute vasculitis affecting children. Early treatment with aspirin and intravenous gamma globulin is crucial for preventing coronary artery aneurysms and long-term cardiac complications.
Area of Science:
- Pediatrics
- Rheumatology
- Cardiology
Background:
- Kawasaki disease is an acute vasculitis with characteristic symptoms including fever, rash, and inflammation.
- Cardiac involvement, such as myocarditis and coronary artery aneurysms, is a significant concern.
- The etiology remains unknown, with an infectious agent suspected.
Purpose of the Study:
- To summarize the clinical presentation, cardiac effects, and management of Kawasaki disease.
- To highlight the long-term risks, particularly coronary artery abnormalities.
- To emphasize the need for careful follow-up and consider Kawasaki disease as a potential coronary disease risk factor.
Main Methods:
- Review of clinical characteristics and known outcomes of Kawasaki disease.
- Analysis of early and late cardiac manifestations.
- Evaluation of current treatment strategies and long-term prognosis.
Main Results:
- Early cardiac effects include myocarditis and pericardial inflammation; coronary artery aneurysms are a long-term risk.
- Intravenous gamma globulin and aspirin are standard treatments to prevent aneurysms.
- Giant aneurysms increase the risk of obstructive coronary disease, potentially requiring bypass grafts.
Conclusions:
- Kawasaki disease requires prompt management to mitigate cardiac risks.
- Long-term follow-up is essential, especially for patients with coronary abnormalities.
- Childhood Kawasaki disease may be a risk factor for future coronary artery disease, particularly in Western populations.
Abstract:
Kawasaki disease is an acute vasculitis characterized by mucosal inflammation, rash, cervical adenopathy, indurative edema of the hands and feet, and late membranous desquamation of the fingertips. Early cardiac effects include myocarditis (occasionally with congestive heart failure), pericardial inflammation, and, rarely, valve involvement. Coronary artery aneurysms are a long-term concern because coronary thrombosis with myocardial infarction can be a late manifestation. The origin of Kawasaki disease is unknown, but an infectious agent is most likely. Management consists of aspirin for control of fever and inflammatory manifestations and intravenous gamma globulin for the prevention of coronary aneurysm formation. Careful late follow-up is required, especially for patients with persistent coronary abnormalities. Giant aneurysms (greater than 8 mm) are more likely to progress to coronary obstructive disease, and coronary bypass grafts have been required for some patients. Late coronary artery manifestations in patients with mild early coronary dilatation have not been described. However, since long-term epidemiologic studies have not yet been performed, it is prudent to consider childhood Kawasaki disease to be a potential risk factor for coronary disease, especially in atherosclerosis-prone Western societies.
Related Concept Videos
Mitral Stenosis III: Medical Management
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management

